Skip to main content
. 2020 Oct 14;59(Suppl 4):iv58–iv66. doi: 10.1093/rheumatology/keaa464

Table 1.

AxSpAs: key genetic features

axSpAs HLA-B27 association Other HLA-associations Non-MHC associations
IL23R ERAP1 ERAP2 MEFV
AS 89% [1] Risk: B40, B47, B51, A2, DRB1*0103 Protective: B7, B57 [2] Yes [3] Yes [3] Yes [3] Yes [4]
nr-axSpA Radiographic arm 58% [5] Unknown Unknown Unknown Unknown Unknown
Psoriasisa No C*0602, C*1203 [6] Yes [7, 8] Yes [9] Yes [9] Unknown
PsA 64% (axial disease) [10] C*0602, A2, B38, B39 [6] Yes [11] Yes [12] Probable [13] Probable [14]
IBD-associated SpA 41% (axial disease) [15] Unknown Yesb Nob Yesb Probable [16]b
Reactive arthritis 16–80% [17] Unknown Unknown Unknown Unknown Unknown
Sarcoidosis arthritis Unclear DQ2-DR3 [18] Unknown Unknown Unknown Unclear
Behçet’s disease No B51 [19] Yes [20] Yes [20] No [21] Probable [22]
FMF Unknown Unknown Unknown Unknown Unknown Yes [23]
a

Included as a comparator for PsA, although not an axSpA.

b

IBD overall, not restricted to those with arthritis.

Probable means P >0.05–<10–5. Unclear means contradictory studies exist.